Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
Clinical trial NCT02037230 · COMPLETED
Trial details
- NCT number
- NCT02037230
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2018-08-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.